AKT1 and rheumatoid arthritis: In recent years, the PI3K/Akt signaling pathway has been recognized as a pivotal regulator in various cellular processes and has emerged as a prominent pharmacological target in the treatment of RA, representing one of the most active areas of inflammation research [51].